| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.247 | 15.102 | 17.480 | 28.795 | 25.293 | 34.039 | 63.256 | 43.931 | 36.473 | 35.121 |
| Total Income - EUR | 15.248 | 15.104 | 17.482 | 28.796 | 25.294 | 34.040 | 63.256 | 43.931 | 36.485 | 35.161 |
| Total Expenses - EUR | 7.299 | 16.012 | 16.872 | 21.212 | 20.872 | 18.082 | 21.093 | 27.182 | 25.494 | 23.255 |
| Gross Profit/Loss - EUR | 7.949 | -907 | 611 | 7.583 | 4.422 | 15.958 | 42.163 | 16.749 | 10.991 | 11.907 |
| Net Profit/Loss - EUR | 7.492 | -1.118 | 436 | 7.295 | 4.169 | 15.623 | 41.544 | 16.353 | 10.681 | 11.597 |
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Bioservet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 203 | 611 |
| Current Assets | 7.065 | 6.835 | 6.595 | 13.873 | 17.813 | 31.496 | 41.377 | 18.473 | 12.920 | 14.543 |
| Inventories | 0 | 0 | 0 | 458 | 449 | 440 | 431 | 0 | 0 | 0 |
| Receivables | 1.998 | 1.899 | 1.842 | 1.808 | 2.723 | 4.644 | 8.377 | 3.826 | 4.399 | 5.922 |
| Cash | 5.067 | 4.936 | 4.753 | 11.607 | 14.640 | 26.411 | 32.570 | 14.646 | 8.521 | 8.621 |
| Shareholders Funds | 6.625 | 5.440 | 5.784 | 12.972 | 16.890 | 32.193 | 41.786 | 18.799 | 10.924 | 11.896 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 440 | 1.395 | 811 | 901 | 923 | 1.245 | 2.249 | 1.422 | 3.114 | 3.533 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Bioservet Srl